未登录 分享 收藏
Avelumab-cetuximab-radiotherapy (RT) versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Final analysis of randomized phase III GORTEC 2017-01 REACH trial 阿维鲁姆单抗-西妥昔单抗-放疗(RT)与标准治疗在局部晚期头颈鳞状细胞癌(LA-SCCHN)患者中的比较：随机III期GORTEC 2017-01 REACH试验的最终分析 Tao, Y.; Auperin, A.; Sun, X.; Liem, X.; Sire, C.; Martin, L.; Pointreau, Y.; Borel, C.; Kaminsky-Forrett, M-C.; Miroir, J.; Rolland, F.; Coutte, A.; Clatot, F.; Sinigaglia, L.; Thariat, J.; Even, C.; Saada, E. B.; Guigay, J.; Bourhis, J. 分享 收藏
Adapted EXTREME regimen in the first-line treatment of fit older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, singlearm, phase 2 trial Guigay, Joel; Le Caer, Herve; Ferrand, Francois-Regis; Geoffrois, Lionel; Saada-Bouzid, Esma; Fayette, Jerome; Sire, Christian; Cupissol, Didier; Blot, Emmanuel; Guillet, Pierre; Pavillet, Julien; Bozec, Laurence; Capitain, Olivier; Rolland, Frederic; Debourdeau, Philippe; Pointreau, Yoann; Falandry, Claire; Lopez, Stephane; Coutte, Alexandre; Chatellier, Thierry; Dalloz, Pierre; Ortholan, Cecile; Michel, Cecile; Lacas, Benjamin; Cheurfa, Nadir; Schwob, Dominique; Bourhis, Jean; Mertens, Cecile; Auperin, Anne 分享 收藏
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3trial Guigay, Joel; Ortholan, Cecile; Vansteene, Damien; Cupissol, Didier; Even, Caroline; Kaminsky, Marie -Christine; Sire, Christian; Blot, Emmanuel; Debourdeau, Philippe; Bozec, Laurence; Saada-Bouzid, Esma; Fayette, Jerome; Dalloz, Pierre; Pointreau, Yoann; Le Caer, Herve; Falandry, Claire; Digue, Laurence; Braccini, Antoine; Lopez, Stephane; Guillet, Pierre; Michel, Cecile; Cheurfa, Nadir; Schwob, Dominique; Bourhis, Jean; Mertens, Cecile; Auperin, Anne 分享 收藏
Cetuximab every 2 weeks versus standard weekly dosing administration schedule 西妥昔单抗每2周给药与标准每周给药方案 Bokemeyer, Carsten; Ciardiello, Fortunato; Dubreuil, Olivier; Guigay, Joel; Kasper, Stefan; Pfeiffer, Per; Pinto, Carmine; Yamaguchi, Kensei; Yoshino, Takayuki; Zielinski, Christoph; Esser, Regina; Tabernero, Josep 分享 收藏
Nivolumab (nivo) in recurrent and/or metastatic squamous cell carcinoma of head and neck (R/M SCCHN): real-world effectiveness, quality of life (QoL) of patients and their caregivers in France (ProNiHN study) Le Tourneau, C.; Even, C.; Salas, S.; Pointreau, Y.; Ceruse, P.; Babin, E.; Fayette, J.; Rondeau, V.; Grumberg, V.; Cotte, F-E.; Govart, A.; Baumstarck, K.; Guigay, J. 分享 收藏
Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) plus durvalumab (D): Results of the tumor mutational burden-high (TMB-h) and/or microsatellite instability-high (MSI-h) cohort of the MOVIE study Hervieu, A.; Guigay, J.; Borcoman, E.; Lavaud, P.; Coquan, E.; Frenel, J-S.; Rouge, T. De La Motte; Augereau, P.; Cropet, C.; Legrand, F.; Goncalves, A. 分享 收藏
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial Galot, Rachel; Le Tourneau, Christophe; Saada-Bouzid, Esma; Daste, Amaury; Even, Caroline; Debruyne, Philip; Henry, Stephanie; Zanetta, Sylvie; Rutten, Anemie; Licitra, Lisa; Canon, Jean-Luc; Kaminsky, Marie-Christine; Specenier, Pol; Rottey, Sylvie; Guigay, Joel; Kong, Anthony; Tinhofer, Inge; Borcoman, Edith; Dirix, Lieve; Raveloarivahy, Tiana; Fortpied, Catherine; Vanlancker, Maureen; Morfouace, Marie; Govaerts, Anne-Sophie; Machiels, Jean-Pascal 分享 收藏
Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck 免疫检查点抑制剂在老年 (≥ 70岁) 头颈部鳞状细胞癌患者中的疗效和安全性 Saleh, Khalil; Auperin, Anne; Martin, Nicolas; Borcoman, Edith; Torossian, Nouritza; Iacob, Mariana; Ferrand, Francois-Regis; Khalife, Nadine; Baste, Neus; Guigay, Joel; Le Tourneau, Christophe; Daste, Amaury; Saada-Bouzid, Esma; Even, Caroline 分享 收藏
Tremelimumab (T) plus durvalumab (D) combined with metronomic oral vinorelbine (MOV): Results of the recurrent cervical cancer (RCC) cohort of the MOVIE study Frenel, J-S.; Hervieu, A.; Borcoman, E.; Coquan, E.; Guigay, J.; Rouge, T. De la Motte; Lavaud, P.; Cropet, C.; Legrand, F.; Goncalves, A. 分享 收藏
Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial Bourhis, J.; Tao, Y.; Sun, X.; Sire, C.; Martin, L.; Liem, X.; Coutte, A.; Pointreau, Y.; Thariat, J.; Miroir, J.; Rolland, F.; Kaminsky, M-C.; Borel, C.; Maillard, A.; Sinigaglia, L.; Guigay, J.; Saada-Bouzid, E.; Even, C.; Auperin, A. 分享 收藏
Impact of sarcopenia (S) on efficacy and toxicity of nivolumab (N) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study Muratori, L.; Texier, M.; Mayache-Badis, L.; Bidault, F.; Iacob, M.; Daste, A.; Fayette, J.; Lefebvre, G.; Saada-Bouzid, E.; Zanetta, S.; Toullec, C.; Cupissol, D.; Salas, S.; Kaminsky-Forrett, M-C.; Johnson, A. C.; Ferrand, F. R.; Auperin, A.; Guigay, J.; Raynard, B.; Even, C. 分享 收藏
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma Marret, Gregoire; Isambert, Nicolas; Rezai, Keyvan; Gal, Jocelyn; Saada-Bouzid, Esma; Rolland, Frederic; Chausson, Maggy; Borcoman, Edith; Alt, Marie; Klijanienko, Jerzy; Vansteene, Damien; Guigay, Joel; Kamal, Maud; Bieche, Ivan; Le Tourneau, Christophe 分享 收藏
Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH) Avelumab-西妥昔单抗-放射治疗与局部晚期头颈部鳞状细胞癌的护理标准: 一项随机III期试验的安全阶段GORTEC 2017-01 (REACH) Tao, Yungan; Auperin, Anne; Sun, Xushan; Sire, Christian; Martin, Laurent; Coutte, Alexandre; Lafond, Cedrik; Miroir, Jessica; Liem, Xavier; Rolland, Frederic; Even, Caroline; Nguyen, France; Saada, Esma; Maillard, Aline; Colin-Batailhou, Natacha; Thariat, Juliette; Guigay, Joel; Bourhis, Jean 分享 收藏
Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 PembroRad randomized trial Bourhis, J.; Sire, C.; Tao, Y.; Martin, L.; Alfonsi, M.; Prevost, J. B.; Rives, M.; Lafond, C.; Tourani, J. M.; Biau, J.; Geoffrois, L.; Coutte, A.; Liem, X.; Vauleon, E.; Drouet, F.; Pechery, A.; Guigay, J.; Wanneveich, M.; Auperin, A.; Sun, X. 分享 收藏
TOPNIVO - A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): Final analysis Even, C.; Daste, A.; Fayette, J.; Lefebvre, G.; Saada-Bouzid, E.; Zanetta, S.; Toullec, C.; Cupissol, D.; Salas, S.; Kaminski, M. C.; Johnson, A. C.; Vauleon, E.; Le Tourneau, C.; Sire, C.; Prevost, A.; Jallut, I.; Bourhis, J.; Guigay, J.; Auperin, A.; Texier, M. 分享 收藏
Avelumab (anti-PD-L1) in patients with platinum-refractory/ineligible recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Results from a phase Ib cohort Avelumab (anti-PD-L1) 治疗铂类难治性/不合格的复发或转移性头颈部鳞状细胞癌 (R/M SCCHN): Ib期队列的结果 Guigay, J.; Lee, K-W.; Patel, M. R.; Daste, A.; Wong, D. J.; Goel, S.; Gordon, M.; Gutierrez, M.; Balmanoukian, A.; Le Tourneau, C.; Mita, A.; Vansteene, D.; Keilholz, U.; Schoffski, P.; Grote, H. J.; Zhou, D.; Bajars, M.; Penel, N. 分享 收藏
Germinal immunogenetics and response to nivolumab in recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC) patients (pts): TopNIVO ancillary study Saada, E. B.; Koudou, Y.; Daste, A.; Fayette, J.; Lefebvre, G.; Zanetta, S.; Toullec, C.; Cupissol, D.; Salas, S.; Kaminsky-Forrett, M-C.; Johnson, A. C.; Vauleon, E.; Ebran, N.; Schmidt, M.; Texier, M.; Peyrade, F.; Milano, G.; Guigay, J.; Even, C.; Etienne-Grimaldi, M-C. 分享 收藏
Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics (vol 10, 3565, 2020) Refae, Sadal; Gal, Jocelyn; Brest, Patrick; Giacchero, Damien; Borchiellini, Delphine; Ebran, Nathalie; Peyrade, Frederic; Guigay, Joel; Milano, Gerard; Saada-Bouzid, Esma 分享 收藏
Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics Refae, Sadal; Gal, Jocelyn; Brest, Patrick; Giacchero, Damien; Borchiellini, Delphine; Ebran, Nathalie; Peyrade, Frederic; Guigay, Joel; Milano, Gerard; Saada-Bouzid, Esma 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
.png){kind=icon}
分享.png){kind=icon}
收藏